Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar:112S:18-27.
doi: 10.1016/j.jsat.2020.02.002.

Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future

Affiliations

Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future

Ali Jalali et al. J Subst Abuse Treat. 2020 Mar.

Abstract

Economic evaluations provide evidence that informs stakeholders on how to efficiently allocate real and financial healthcare resources. The purpose of this study was to review and discuss the integration of economic evaluations into the National Drug Abuse Treatment Clinical Trials Network (CTN) since its inception, as well as expectations for the future of this relationship. A systematic review was performed on published and planned CTN economic evaluations in the CTN dissemination library and PubMed. The well-established Drummond checklist was used to evaluate the comprehensiveness and methodological rigor of published articles. One hundred thirty-eight ancillary, follow-up, or original protocols were reviewed, and 78 potentially relevant published articles were identified. A total number of 14 protocols included an economic evaluation. Of these, 6 protocols were completed, 2 were reported as active, and 6 were reported as in-development at the time of this review. Of the 78 published articles, 9 met the inclusion criteria. As gauged by the Drummond checklist, the quality of CTN published economic evaluations were found to improve over time, and recent published articles were identified as guides to cutting-edge economic research. As the CTN continues to grow and mature, it is imperative that high-quality economic evaluations are incorporated alongside trials in order to maximize the public health impact of the CTN.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest This research was supported in part by the National Institute on Drug Abuse (P30DA040500, R01DA035808, R01DA046721, UG1DA040314, UG1DA013732, UG1DA013035, UG1DA015831, UG1DA040309). The content of this article is solely the responsibility of the authors and does not necessarily represent the official view of the funding agency or the US government.

Figures

Figure 1.
Figure 1.
Diagram of Published CTN Economic Evaluations
Figure 2.
Figure 2.
Cumulative Published CTN Economic Evaluations: 2000–2020 Notes: Line and markers indicate the number of CTN-associated economic analyses that met the inclusion criteria published over time.
Figure 3.
Figure 3.
Diagram of Completed, Active, and In-Development CTN Protocols with Economic Evaluations

References

    1. Alter MJ (2006). Epidemiology of viral hepatitis and HIV co-infection. J Hepatol, 44(1 Suppl), S6–9. - PubMed
    1. Balestroni G, & Bertolotti G. (2012). [EuroQol-5D (EQ-5D): an instrument for measuring quality of life]. Monaldi Arch Chest Dis, 78(3), 155–159. - PubMed
    1. Braithwaite RS, Meltzer DO, King JT Jr., Leslie D, & Roberts MS (2008). What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care, 46(4), 349–356. - PubMed
    1. Brauer CA, Neumann PJ, & Rosen AB (2007). Trends in cost effectiveness analyses in orthopaedic surgery. Clin Orthop Relat Res, 457, 42–48. - PubMed
    1. Briggs AH, & O’Brien BJ (2001). The death of cost-minimization analysis? Health Econ, 10(2), 179–184. - PubMed

Publication types